|
NIN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.489620E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.386200E-02 |
| Normal-vs-Stage2 |
2.121800E-02 |
| Normal-vs-Stage3 |
7.099600E-03 |
| Normal-vs-Stage4 |
1.236010E-02 |
| Stage1-vs-Stage2 |
5.419200E-01 |
| Stage1-vs-Stage3 |
1.452170E-01 |
| Stage1-vs-Stage4 |
2.608400E-01 |
| Stage2-vs-Stage3 |
6.490800E-01 |
| Stage2-vs-Stage4 |
6.728600E-01 |
| Stage3-vs-Stage4 |
9.864600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.897700E-02 |
| Normal-vs-AfricanAmerican |
9.884600E-03 |
| Normal-vs-Asian |
1.626240E-02 |
| Caucasian-vs-AfricanAmerican |
3.245800E-01 |
| Caucasian-vs-Asian |
4.641400E-01 |
| AfricanAmerican-vs-Asian |
5.082800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.700260E-02 |
| Normal-vs-Female |
1.701760E-02 |
| Male-vs-Female |
7.594000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.105040E-01 |
| Normal-vs-Age(41-60Yrs) |
2.298200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.793760E-02 |
| Normal-vs-Age(81-100Yrs) |
3.905200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.138270E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.199150E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.926200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.571600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.945000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.482200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.163000E-01 |
| Classical-VS-Follicular |
2.977600E-04 |
| Classical-VS-Other |
6.820200E-02 |
| Classical-VS-Normal |
6.498300E-02 |
| Tall-VS-Follicular |
2.669000E-01 |
| Tall-VS-Other |
1.260640E-01 |
| Tall-VS-Normal |
8.184000E-02 |
| Follicular-VS-Other |
4.642000E-01 |
| Follicular-VS-Normal |
6.414700E-04 |
| Other-VS-Normal |
1.941070E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.861200E-03 |
| Normal-vs-N1 |
9.035500E-03 |
| N0-vs-N1 |
9.473400E-01 |
|
|
